About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Houston | 429 Studies

Clinical Trials MelanomaHouston

Melanoma Clinical Trials in Houston

Find 429 clinical trials for melanoma near Houston, Texas. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 429 trials

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedLive Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid TumorsThis is an open label, safety and preliminary efficacy study of MRx0518 in combination with pembrolizumab in patients with solid tumours (non small cell lung cancer, renal cell…NCT03637803·Kansas City, Kansas and 4 others

CompletedPembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic MelanomaThis randomized phase II trial studies how well giving pembrolizumab with standard chemotherapy, tumor infiltrating lymphocytes (TIL), and aldesleukin works in treating patients…NCT02500576·Houston, Texas

CompletedSafety Study of IL-21/Ipilimumab Combination in the Treatment of MelanomaThe purpose of this study is to determine whether the combination of interleukin-21 (IL-21) and Ipilimumab in subjects with melanoma is safe, and provide preliminary information…NCT01489059·Scottsdale, Arizona and 8 others

CompletedMicroarray Analysis for Human Genetic DiseaseThis study will look at genetic changes which occur in the development of male and female breast cancer and other cancer.NCT00001898·Tucson, Arizona and 7 others

CompletedA Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid TumorsThis is a dose-escalation, Phase I/II, open-label, three-part study.NCT02065063·Boston, Massachusetts and 2 others

Active not recruitingA Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid TumorsTo learn if KSQ-001EX is safe to give to participants with advanced forms of solid tumors.NCT06237881·Houston, Texas

Active not recruitingA Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022.NCT02817633·Goodyear, Arizona and 88 others

CompletedIpilimumab and Imatinib Mesylate in Advanced CancerThis phase I trial studies the side effects and best dose of ipilimumab and imatinib mesylate in treating patients with solid tumors that have spread to other places in the body…NCT01738139·Houston, Texas

Not yet recruitingSI-B036-ST-101 in Advanced/Metastatic Solid TumorsThe objective of the study is to evaluate the safety and tolerability of SI-B036 in participants with solid tumors who have received at least one prior line of therapy for…NCT07857616·New Haven, Connecticut and 6 others

CompletedPhase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesThe purpose of this study of MCS110 with PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of the…NCT02807844·Boston, Massachusetts and 19 others

TerminatedSample Collection From Melanoma PatientsThe goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma.NCT00507325·Houston, Texas

RecruitingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsA Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid TumorsNCT06953089·Los Angeles, California and 36 others

TerminatedDabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D MelanomaThis phase II trial studies how well dabrafenib, trametinib, and spartalizumab works in treating patients with BRAF V600E or V600K mutation positive stage IIIB/C/D melanoma, who…NCT04310397·Houston, Texas

CompletedInterferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With MelanomaRATIONALE: Interferon alfa may interfere with the growth of cancer cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells.NCT00002882·Houston, Texas

CompletedPharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic DysfunctionThe purpose of this study is to see how vincristine, when placed in an oil droplet called a liposome (VSLI), is absorbed, distributed (moved around) and excreted from the the body…NCT00145041·Houston, Texas

CompletedSafety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaTo evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investigator's Choice of dacarbazine…NCT03070392·Los Angeles, California and 56 others

CompletedA Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic MelanomaThis is an open-label, multicenter, Phase Ib, dose-escalation and cohort-expansion study of atezolizumab (anti-programmed death-ligand 1 \[PD-L1\] antibody) in combination with…NCT01656642·Los Angeles, California and 7 others

TerminatedParallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I PortionThe goal of the first phase of this clinical research study is to find the highest tolerable dose of decitabine and peginterferon alfa-2b that can be given in combination to…NCT00791271·Houston, Texas

RecruitingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsThis study will evaluate the safety, efficacy, optimal dose, and pharmacokinetics (PK) of BNT326 as monotherapy (Part 1) and as combination treatment with immunotherapeutic agents…NCT07070232·Phoenix, Arizona and 76 others

PreviousPage 9 of 22Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma